KARBINAL

Welcome to the Brand page for “KARBINAL”, which is offered here for Oral extended release pharmaceutical preparations for the drug carbinoxamine, intended for the treatment of seasonal and perennial allergic rhinitis;.

Its status is currently believed to be active. Its class is unavailable. “KARBINAL” is believed to be currently owned by “TRIS PHARMA, INC”.


Owner:
TRIS PHARMA, INC
Owner Details
Description:
Oral extended release pharmaceutical preparations for the drug carbinoxamine, intended for the treatment of seasonal and perennial allergic rhinitis;
Categories: ORAL EXTENDED RELEASE PHARMACEUTICAL PREPARATIONS